Irish firm’s cutting-edge pet drugs have potential for human use | Business Post

Belgique Nouvelles Nouvelles

Irish firm’s cutting-edge pet drugs have potential for human use | Business Post
Belgique Dernières Nouvelles,Belgique Actualités

Waterford-based TriviumVet is raising more than €5 million in the next month to launch new treatments for cats and dogs, which have the potential to also treat people, donalmacnamee97 reports.

Louise Grubb chief executive of Trivium Vet: ‘The actual disease of HCM in cats is a model of what it’s like in humans, for which there isn’t a very effective treatment.’ Picture: Colin Shanahan

The company was founded in 2015 by Louise Grubb, who previously founded pharma storage company Q1 Scientific, as well as Tom Brennan, whose EirGen Pharma was bought by Opko Health in 2015 for around €120 million. “The actual disease of HCM in cats is a model of what it’s like in humans, for which there isn’t a very effective treatment,” Grubb said.

“We’ve . . . really valuable research done in dogs and cats, and we think we can use that to help in the human sphere,” Grubb said.TriviumVet, which has backing from Enterprise Ireland and employs 12 people, did not initially intend to move into the sphere of human healthcare, Grubb said. The original plan – which still stands today, and is developing all the time – was to examine diseases in cats and dogs for which there was no effective treatment, and to plug that gap.

 

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Subsidised companies and dividends, consumer sentiment falls, and crypto oversightSubsidised companies and dividends, consumer sentiment falls, and crypto oversightSubsidised companies and dividends, consumer sentiment falls, and crypto oversight via IrishTimesBiz
Lire la suite »



Render Time: 2025-01-09 20:47:03